| AEROPATH |
Identification, characterisation and exploitation of novel Gram-negative drug targets |
| AntiPathoGN |
Identification and validation of novel drug targets in Gram-negative bacteria by global search: a trans-system approach |
| ANTIRESDEV |
The effects of antibiotic administration on the emergence and persistence of antibiotic-resistant bacteria in humans and on the composition of the indigenous microbiotas at various body sites |
| CAREPNEUMO |
Combating Antibiotics Resistant Pneumococci by Novel Strategies Based on in vivo and in vitro Host-Pathogen Interactions |
| CONCORD |
CONtrol of COmmunity-acquired MRSA: Rationale and Development of counteractions |
| DIVINOCELL |
Exploiting Gram-negative cell division targets in the test tube to obtain antimicrobial compounds |
| HYPERDIFF |
The Physiological Basis of Hypervirulence in Clostridium difficile: a Prerequisite for Effective Infection Control |
| NABATIVI |
Novel Approaches to Bacterial Target Identification, Validation and Inhibition |
| PAR |
Predicting antibiotic resistance |
| PILGRIM |
Preventing community and nosocomial spread and Infection with MRSA ST 398 - instruments for accelerated control and integrated risk management of antimicrobial resistance |
| PNEUMOPATH |
A comprehensive dissection of pneumococcal-host interactions |
| SATURN |
Impact of Specific Antibiotic Therapies on the prevalence of hUman host ResistaNt bacteria |
| SYBARIS |
Finding biomarkers of anti-microbial drug resistance via a systems biology analysis of fungal pathogen interactions with the human immune system |
| TEMPOtest |
An Integrated Tool-Kit for the Clinical Evaluation of Microbial Detection and Antibiotic Susceptibility Point-of-Care Testing Technologies |
| TROCAR |
Translation Research On Combating Antimicrobial Resistance |
